Skip to main content
Premium Trial:

Request an Annual Quote

Integromics Licenses Proteomics LIMS Software to Princeton University

Premium

Integromics has licensed its OmicsHub Proteomics laboratory information management system to Princeton University's Mass Spectrometry Center for use in managing and analyzing mass spec data, the company said this week.

Integromics said it plans to deploy OmicsHub as part of a "functional data analysis infrastructure" it will have in place at the center by the end of the year.

Additional details were not disclosed.

Michael McManus, Integromics' CEO, said that the university's decision to use OmicsHub represents "a significant step" for the company "towards the expansion of Integromics from the genomics to the proteomics data management field."

In an interview with BioInform shortly after he took over the reins at Integromics in October, McManus noted that the need for tools to manage proteomics data has been "somewhat lost" due to the recent buzz around next-generation sequencing. However, he added, "it's just as severe a problem and we do have a lot of people who have come to us looking for solutions relating to proteomics."

At the time, McManus, who was hired to expand the company's presence in the US and Asian markets as well as to direct its move into next-generation sequencing space, said that the firm planned to develop additional modules for OmicsHub that were aimed at making proteomics data management easier for researchers, although he did not provide specific details about what those capabilities would be (BI 10/08/2010).

OmicsHub was developed by Integromics in collaboration with the Spanish National Institute for Proteomics and the Proteome Xchange.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.